Our data indirectly suggests that interleukin-6 originating from fat tissue may play a role in overweight- and obesity-related CVD, because CRP decreased the BMI-associated CVD risk markedly [38], and because it is well known that CRP itself is only a marker not a cause of CVD [39]. This evidence concerns the gene CRP and obesity disorder.